F
FENNEC PHARMACEUTICALS INC
NASDAQ: FENC (Fennec Pharmaceuticals Inc.)
Last update: 1 hour ago10.61
-0.01 (-0.14%)
| Previous Close | 10.62 |
| Volume | 105,063 |
| Price / Earnings (Forward) | 10.57 |
| Price / Sales | 5.94 |
| Price / Book | 8.68 |
| 52 Weeks Range |
| Profit Margin | -46.71% |
| Operating Margin (TTM) | -9.23% |
| Diluted EPS (TTM) | -0.530 |
| Quarterly Revenue Growth (YOY) | -65.50% |
| Current Ratio (MRQ) | 5.13 |
| Operating Cash Flow (TTM) | -16.39 M |
| Levered Free Cash Flow (TTM) | -9.65 M |
| Return on Assets (TTM) | -12.96% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (US) | Mixed | Bullish |
| Biotechnology (Global) | Mixed | Bullish | |
| Stock | Fennec Pharmaceuticals Inc. | Mixed | Bullish |
AIStockmoo Score
-0.5
| Analyst Consensus | NA |
| Insider Activity | -1.5 |
| Price Volatility | -1.5 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | -0.5 |
| Average | -0.50 |
|
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States. |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| Investment Style | Small Growth |
| % Held by Insiders | 16.29% |
| % Held by Institutions | 57.51% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Rosalind Advisors, Inc. | 30 Jun 2026 | 3,188,001 |
| Prospect Capital Advisors, Llc | 30 Jun 2026 | 497,800 |
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| BRUGHERA MARCO MARIA | - | 10.64 | -15,545 | -165,399 |
| Aggregate Net Quantity | -15,545 | |||
| Aggregate Net Value ($) | -165,399 | |||
| Aggregate Avg. Buy ($) | - | |||
| Aggregate Avg. Sell ($) | 10.64 | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| BRUGHERA MARCO MARIA | Director | 15 Sep 2026 | Automatic sell (-) | 15,545 | 10.64 | 165,399 |
| BRUGHERA MARCO MARIA | Director | 15 Sep 2026 | Option execute | 15,545 | - | - |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |